SHL Auto Injectors, Pen Injectors and Inhaler Systems
SHL Group is a solutions provider in the design, development, and manufacturing of advanced drug delivery systems.
The company’s international team of experienced designers and engineers develop product enhancements and breakthrough drug delivery solutions for clients worldwide.
Research, innovation, and design of drug delivery devices
SHL has invested significantly in the research and development (R&D) of next-generation drug delivery devices, including a range of disposable and reusable injectors with fixed or variable dosing, high-dose accuracy, and the ability to accommodate high volumes and high viscosities.
The company’s team of industrial designers work closely with clients and end-user groups to ensure that their needs are translated and incorporated into the design of the device.
In addition, SHL is invested in digital solutions beyond injection devices. Combining internal knowledge and experience with active partnerships, the SHL Group has launched a number of initiatives in the digital space to bring innovation to the market.
High-quality in-house manufacturing for quick time-to-market
SHL is a renowned, high-quality, and high-volume manufacturer of drug delivery devices. Its key manufacturing capabilities ensure high-quality products and an increased time-to-market.
Developing drug delivery devices in-house allows SHL to customise existing platforms in its pipeline or develop completely new bespoke devices based on the unique requirements of its clients. Its capabilities include:
- An advanced in-house tooling centre for drug delivery devices
- An extensive range of moulding solutions
- Customised, automated assembly and testing equipment
- High-precision, computer numerical control (CNC) machining centres
- Precision inspection of product components and equipment parts
- Semi-automatic and fully-automatic assembly solutions
Final assembly, labelling, and packaging for drug delivery devices
SHL provides final assembly, labelling, and packaging services for drug delivery devices to the pharmaceutical and biotechnology industries.
These services were established to streamline the production and distribution process for the company’s injection products to bring high-quality end-products and faster time-to-market to clients worldwide.
By integrating an additional piece of the supply chain, SHL offers a fully comprehensive experience for its customer’s drug delivery products.
- Device and primary packaging characterisation
- Final assembly of auto-injectors or pen injectors
- Labelling and secondary packaging, as well as kitting of assembled devices
Drug delivery commercialisation solutions and regulatory compliance
SHL’s international team of dedicated professionals ensure that customer expectations are met and final products are delivered at optimal quality and speed.
The company provides a comprehensive range of services to meet clients’ project requirements:
ISO13485 and US Food and Drug Administration (FDA) 21 CFR 820 compliant
Support for regulatory life-cycle management
Comprehensive strategy to safeguard customer intellectual property (IP)
Dedicated professionals to ensure success of customer projects
Scalable storage and customisable global shipping strategies
SHL is forward-looking company with extensive knowledge and experience. The company has locations in Taiwan, Sweden, the US, and China among its group companies SHL Medical, SHL Healthcare, and SHL Technologies.
SHL Technologies is a contract development and manufacturing organisation (CDMO) that provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for various industrial sectors. This includes the production of electronics, medical devices, and plastics, with products such as neurosurgical equipment, electronic stethoscopes, advanced digital diagnostic catheters, polychlorinated biphenyl (PCB) printing machine modules, solar cell printing machine modules, and integrated circuit (IC) testing machine modules.
SHL Healthcare develops and manufactures equipment solutions for home, hospital, and long-term care use with a focus on patient comfort and functionality. Its broad range of products include medical slings, rehabilitation beds, pressure mattress systems, lifting equipment, medical soft goods, and a variety of related accessories.
SHL Medical works with leading biotechnology and pharmaceutical companies to develop cutting-edge drug delivery systems such as compact disposable auto injectors, reusable pen injectors, and complex inhaler systems. These devices are based on standard prefilled syringes (PFS) and cartridges, as well as novel primary containers.
Products and Services
SHL’s extensive range of auto-injectors redefine the self-injection process as they are simple, safe, and reliable.
Pen Injectors (Maddie)
SHL’s pen injectors offer features such as variable dosing, dose limit memory settings, full control over the injection process, disposable or reusable options, compactness, and stylish industrial designs.
High-Viscosity Solutions (PPI)
Growing demand for treatments using biological drugs has created a challenge for injectable devices to deliver high-viscosity, next-generation formulations while putting patient comfort and usability first.
Digital solutions (Molly C)
Capitalising on its years of experience and knowledge base, SHL offers new and exciting insights into current and future needs, inspiring and guiding further innovation for the drug delivery industry and beyond.
Inhaler Systems (ADI)
Partnering with other experts in this field, SHL has applied for several patents to protect some ground-breaking solutions that it believes will be beneficial to its customers.
Molly is an ultra-compact auto injector that is ideal for convenience and portability.
Molly 2.25 is SHL's first high volume auto injector.
Amber is a single-dose, disposable auto injector with a unique patient-centric design.
Penny is a 3ml multi-dose disposable pen injector that features a user-centred industrial design and simple esthetics.
Precision Pen Injector (PPI)
Precision Pen Injector (PPI) is a multi-use injector with a 2.25 glass syringe, which can be reused up to 200 times.
Autoinjectors: From Planning to Launch
Looking at the rising trend towards self-administration therapies, injectable drug delivery devices such as pen injectors, autoinjectors and needle-free injectors show a significant growth potential in the near future.
Interview with Jochen Ratjen from SHL Group
As self-administrated injection trends continue to increase, auto injector devices are no longer a foreign concept to patients and device designs have shifted towards a user-centric approach.
Streamlining Key Services your Drug Delivery Device Partners Provide
As the market demand for auto-injectors and pen-injectors continues to grow at a rapid pace, greater emphasis is now being placed on which partners can provide integrated solutions to address the needs of biopharmaceutical companies today and help them bring their combination of products to the market.
SHL Group and fast-rising healthcare startup QuiO are pleased to announce a strategic partnership on digital technologies that will take the drug delivery industry into connected therapeutics.Read more
SHL Group has announced that it will be holding a webinar discussing the value of new technologies in digital health and drug delivery systems.Read more
SHL has announced that it will exhibit at Pharmapack Europe in Paris Expo Porte de Versailles Hall 4.Read more
SHL will be showcasing in Booth #411 and Table Top #1 at the PDA Universe of Pre-filled Syringes & Injection Devices Event.Read more
To stay innovative and competitive as a leading provider in advanced drug delivery devices such as auto injectors and pen injectors, SHL continuously invests in developing new pragmatic products that reflect industry trends and end-user needs.Read more
With rapid growth of SHL Group and new innovations and technologies developed for pen and auto injectors, the Taoyuan facility requires expansion, and will be relocating to a the new site in Nankan, Taoyuan.Read more
At Pharmapack Europe at Paris Expo, Porte de Versailles, SHL will be featuring Molly 2.25, a high volume auto injector, as well as Molly C, a newly developed product related to connectivity.Read more
Within two years of reaching a milestone of 2,500 employees, SHL Group has reached 3,000 employees worldwide.Read more
As an international organisation that provides for the global market, SHL is excited to announce the addition of Spanish, one of the most prolific languages in the world, to the company's corporate website.Read more
The design, development and manufacturing of a successful auto injector project requires not only seamless collaboration between the biopharmaceutical company and key partners, but also robust design and manufacturing capabilities that can reflect the device characteristics.Read more
SHL will be holding a webinar through Pharmaceutical Business Review on 17 June at 3pm in London / 10am in New York on 'Prerequisites for a successful drug delivery device development programme.'Read more
The Emerade Adrenaline Auto Injector is available for download from SHL Medical's website.Read more
In an immediate response to the earthquake that left Nepal in ruins on 25 April, SHL reached out to World Vision to hold an internal donation event at its key manufacturing sites in Taiwan, where a booth is being set up for staff to contribute donations.Read more
SHL will be exhibiting at the Guide for Prefilled Syringe Seminar 2015 in Tokyo, Japan.Read more
The expansion of the auto injector market has been triggered by the need for improvements in quality of life (QOL) and patient compliance.Read more
SHL Nominated for Financial Times Standard Chartered Taiwan Business Award for Economic Contribution
SHL has recently been nominated as one of the top three companies in Taiwan for the FT-Standard Chartered Taiwan Business Award in the Economic Contribution category.Read more
The global injectable drug delivery device technologies market was valued at approximately $10.2bn in 2012 and is expected to grow at a CAGR rate of 11% to $17.2bn by 2017.Read more
At the forthcoming Management Forum Injectable Drug Delivery conference, SHL executive vice-president Mats Persson is to give a talk entitled 'Latest Self Injection Trends'. It will cover a range of topics, from the benefits of auto injectors to trends of biologics.Read more
SHL will be attending the upcoming 18th annual Drug Delivery Partnerships conference event in Bota Raton, Florida, US, where marketing director Steven Kaufman will speak on the topic of recent and upcoming trends in drug delivery devices such as auto injectors and pen injectors.Read more
According to a recent industry report, more than 75% of biologics are administered either subcutaneously or intramuscularly via a form of drug delivery technology, and with the continuous surge of biologics in biopharma company pipelines worldwide, the drug delivery technologies market is anticipated to grow to over $224bn in the next few years.Read more
Understanding the Types of Design that Should Be Driving Innovation at Drug Delivery Device Suppliers
SHL's recent article, 'Understanding which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers', featured in OnDrugDelivery's October 2013 issue 'Prefilled Syringes: The Human Factor'.Read more
It is predicted that the worldwide market for injectable drug delivery technologies will reach $43bn by 2017, with much of it based on drivers such as the rise of biologics and biosimilars, as well as continuously improving patient compliance.Read more
Designer, developer and manufacturer of advanced drug delivery devices SHL has announced reaching a new milestone of 2,000 employees in Taiwan as of 1 September 2013.Read more
SHL Group, the world's largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, signed a second letter of intent (LOI) with the Taiwan Ministry of Economic Affairs to invest an additional $40m in Taiwan.Read more
As demand for self-injection devices such as auto injectors and pen injectors continues to rise, drug delivery device suppliers must design manufacturing operations that are scalable, especially for key capabilities such as moulding and material handling systems.Read more
As SHL Group expands to provide customers with readily available services and production capabilities, the company insists on investing in high quality moulding machines such as those from KraussMaffei.Read more
SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices such as auto injectors and pen injectors, SHL has continued to invest heavily in facilities, advanced machinery and R&D.Read more
SHL will be presenting and exhibiting at the upcoming 10th Annual BIO Asia International Conference from 29 - 30 January in Tokyo, Japan. BIO Asia is the longest running Asian partnering event designed specifically to facilitate collaboration between biopharmaceutical companies and suppliers.Read more
The pharmaceutical market in India is one of the most-watched markets for emerging opportunities in areas like consumer healthcare drugs, biologics, vaccines and more. In fact, according to a recent CII-PwC report, India is projected to be among top 10 pharmaceutical markets globally by 2020.Read more
At the recent 2012 PDA event in Las Vegas, USA, SHL introduced the concept of Inspiring Integration and promoted the importance of working with a drug delivery device partner that provides streamlined key services instead of focusing only on devices.Read more
With the biopharmaceutical industry's drug delivery landscape quickly adapting to the introduction of several biologics drugs in recent years, a range of new devices such as pen and auto injectors have also been introduced to improve administration, safety and accuracy for end-users.Read more
In response to increased customer orders and the signing of long-term contracts, SHL has hired more than 600 new employees over a 14 month period.Read more
As the demand for biologics continues to increase, corresponding growth for advanced drug delivery devices such as auto injectors can also be seen in projections from various established pharmaceutical research agencies.Read more
SHL spoke and exhibited at the Japan PDA's Prefilled Syringe Seminar in Tokyo from 22 until 23 May 2012 and received excellent feedback from many of the conference attendees.Read more
Manufacturing Chemist, an established publication in the biopharmaceutical industry, recently approached SHL to share with their readers the company's knowledge and experience from working with numerous autoinjector development projects.Read more
SHL recently had the opportunity to participate along with various other experts in the industry in a questionnaire held by PharmTech.com on the topic of 'Pointed Debate: Expert Views on Injectables'.Read more
SHL is officially introducing the company's first white paper on the topic of 'Autoinjectors: From Planning to Launch' with the goal of sharing with readers insights on how to prepare for the overall development process from different perspectives, including design, regulatory and manufacturing.Read more
SHL successfully wrapped up this year's exhibition at the PDA's 'The Universe of Pre-filled Syringes and Injection Devices' 2011 event held in Basel, Switzerland, earlier last month.Read more
SHL was recently featured in an article published by BioSpectrum Asia on the topic of 'The Emerging Drug Delivery Landscape'. In the article, SHL is identified as an innovator of auto injectors in Asia and continues to respond to increasing demands by expanding the pipeline of devices and investing more in design expertise and R&D.Read more
An article by SHL Group was recently featured in InPharm's Manufacturing & Production Guide.Read more
SHL will be exhibiting at the 2011 Parental Drug Association (PDA) Europe Conference in Basel, Switzerland, 8-9 NovemberRead more
SHL Group is honoured to have recently received certification for the Good Design Award for its revolutionary auto injector, Molly.Read more
SHL marketing director Steven Kaufman will be speaking at the upcoming Primary Packaging and Drug Delivery Trends for Injectables symposium held by Pharmapack Symposium in Seoul, Korea on 14 October 2011.Read more
With the increasing number of biologics coming to market, the demand for drug delivery solutions such as auto injectors has increased significantly in recent years. This demand is projected to grow even more rapidly in the next five years. While North America and Europe have been key drivers forRead more
Auto Injector Manufacturer SHL Group Featured in Executive Yuan’s ‘Spotlight on Taiwan Bio-Industries’
Taiwan's Executive Yuan Science & Technology Advisory Group recently published 'Spotlight on Taiwan Bio-Industries', which introduces various aspects of the Taiwan biotechnology industry, including global competitiveness, industry highlights, investment incentives and more. In the sRead more
SHL Group is proud to introduce SHL Pharma, a facility built with a greener approach providing final assembly, labelling and packaging services of drug delivery devices such as autoinjectors for the pharmaceutical and biotechnology industries. The addition of SHL Pharma means SHL can noRead more
SHL has just completed an additional expansion of its Nan Kan 6 facility located in northern Taiwan to ensure that adequate production capacity can be maintained for its OEM/ODM customers. CNC, moulding and automation related production have been added to the facility, expanding on our support foRead more
The 2011 DCAT Biologics Forum will focus on trends and best practices for subcutaneous biologic drug delivery systems featuring presentations and discussion with leaders from the FDA, pharma and delivery system component supplier markets. Several key industry experts have been invited to speak atRead more
With a steadily increasing number of biologics coming to market, the demand for autoinjectors and similar devices continues to grow. The goal of events such as Injectable Drug Delivery (The World of Auto, Pen & Needle-Free Injectors: Advances in Devices and Technology) is to bring experts froRead more
With an increasing number of drug delivery devices, primarily autoinjectors and pen injectors, under development and soon entering mass production, SHL Automation has been steadily working towards enhancing SHL's in-house automated sub-assembly solutions. One related development programme involveRead more
SHL and its latest autoinjector Molly have recently been featured in the October 2010 issue of OnDrugDelivery magazine, a publication that showcases different technologies of the drug delivery industry and reaches a large group of targeted readers. In this featured article, titleRead more
After launching a dedicated website for SHL's latest autoinjector Molly, a promotional video has also been tailored for the campaign and will be available through the website and SHL's YouTube channel. The Molly video will be SHL Group's first official promotional video with the objectiRead more
SHL is introducing its first 'pre-configured' auto injector to the B2B market for leading biotechnology and pharmaceutical companies. Molly is an intuitive device featuring an ultra-compact design, simplified two-step operation and a permanently hidden needle. Thanks to the collaborative effortsRead more
SHL, a leading manufacturer of drug delivery devices, will further expand operations in the US with the establishment of SHL Pharma Systems, a state-of-the-art final assembly and packaging operation. Located in South Florida (US), this new facility will offer final assembly, labelling and packagiRead more
136, Kuo Sheng 2nd Street
Box 1240, Augustendalsvagen 19
SE131 28 Nacka Strand
588, Jim Moran Boulevard
United States of America